Zhongshan Ophthalmic Center, Sun Yat-sen University
Guangzhou, Guangdong, China
NCT Number: NCT06633393
The global rise in myopia, particularly among children and adolescents in China, underscores the inadequacy of current prevention strategies, indicating that conventional screening and education alone are insufficient to curb the prevalence. Integrating personalized myopia prediction into routine care may enhance risk awareness, promote proactive prevention, and improve adherence to medical advice, ultimately reducing the future burden of high myopia.
A myopia prediction system based on artificial intelligence was previously developed, accurately predicting future high myopia risk using efficient, robust, and easily accessible predictive factors, including age, spherical equivalent, and the annual progression of spherical equivalent. This study aims to conduct a prospective, one-year, cluster randomized controlled clinical trial to investigate the effectiveness of this prediction system in preventing and controlling myopia in school-aged children.
Trial opening soon.
Get Notified9 year–11 year
All sexes
Interventional
Not applicable
Guangzhou, Guangdong, China
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
At baseline and six months, participants will be provided with the results of their predicted risk of high myopia at age 18 based on the myopia prediction system.
At baseline and six months, participants will be provided with the results of their ophthalmic examinations.
Time frame: 1 year
At the end of the one-year study, the Myopia Prediction System will be used to predict whether students will develop high myopia at age 18 in both the intervention and control groups. The Proportion of Individuals Predicted to Develop High Myopia at Age 18 by the Myopia Prediction System is calculated as the total number of students in each group predicted to develop high myopia by age 18, divided by the total number of students in the respective group.
Time frame: Within 3 months after each intervention
The Cumulative Clinical Visit Rate Proportion of Clinical Visits for Myopia Prevention and Control is the proportion of students in the intervention or control group who visited a hospital or clinic for myopia-related care (e.g., refractive exams and treatment) at least once within three months of either intervention. It is calculated as the number of students in each group who attended a clinical visit within three months of at least one intervention, divided by the total number of students in the respective group.
Time frame: 1 year
1-year myopia incidence rate = number of new myopia cases within one year / number of non-myopic cases at baseline * 100%
Time frame: 1 year
Change in spherical equivalent (non-cycloplegic autorefraction) will be calculated
Time frame: 1 year
Daily usage time of electronic devices (computer/smartphone/tablet computer) will be calculated
Time frame: 1 year
Daily outdoor activity time will be calculated
Contact information is provided by the study sponsor or research team.
Xinwei Chen, M.D.
CONTACT
Yahan Yang, M.D., Ph.D
CONTACT
Zhongshan Ophthalmic Center, Sun Yat-sen University
Other
Impact of Feedback Based on the Myopia Prediction System on High Myopia Risk and Consultation Behavior in School-aged Children: a Cluster Randomized Controlled Trial
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07724210
Eye Diseases, Myopia
Beijing, Beijing Municipality, China
View Trial DetailsNCT07406906
Eye Diseases, Myopia
Hong Kong
View Trial DetailsNCT07721714
Astigmatism, Eye Diseases
Palo Alto, California, United States
View Trial DetailsNCT07696468
Eye Diseases, Myopia
Guangzhou, Guangdong, China
View Trial Details